Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL-22 antibody (Biotin)

IL22 Reactivity: Human ELISA, ELISpot Host: Rat Monoclonal MT7B27 Biotin
Catalog No. ABIN6963887
  • Target See all IL-22 (IL22) Antibodies
    IL-22 (IL22) (Interleukin 22 (IL22))
    Reactivity
    • 73
    • 40
    • 26
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 66
    • 12
    • 8
    • 4
    Rat
    Clonality
    • 69
    • 20
    • 1
    Monoclonal
    Conjugate
    • 48
    • 14
    • 6
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This IL-22 antibody is conjugated to Biotin
    Application
    • 73
    • 46
    • 24
    • 13
    • 13
    • 11
    • 8
    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    ELISA, ELISpot
    Specificity
    Native and recombinant IL-22
    Purification
    Biotinylated through reaction with a N-hydroxysuccinimide ester of biotin.,Purified from in vitro cultures by protein G affinity chromatography.
    Sterility
    0.2 μm filtered
    Immunogen
    Recombinant human IL-22
    Clone
    MT7B27
    Isotype
    IgG2a
    Top Product
    Discover our top product IL22 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
    Expiry Date
    18 months
  • Chen, Gomes, Hardman, Vieira Braga, Gutowska-Owsiak, Salimi, Gray, Duncan, Reynolds, Johnson, Salio, Cerundolo, Barlow, McKenzie, Teichmann, Haniffa, Ogg: "Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation." in: The Journal of experimental medicine, Vol. 217, Issue 3, (2020) (PubMed).

    Monroy-Arreola, Durán-Figueroa, Méndez-Flores, Domínguez-Cherit, Watkinson, Badillo-Corona, Whitaker, Naisbitt, Castrejón-Flores: "Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4+ T-Cells from Hypersensitive Patients." in: Chemical research in toxicology, Vol. 31, Issue 6, pp. 454-461, (2019) (PubMed).

    Ashrafi, Shapouri, Mahdavi: "Immunological consequences of immunization with tumor lysate vaccine and propranolol as an adjuvant: A study on cytokine profiles in breast tumor microenvironment." in: Immunology letters, Vol. 181, pp. 63-70, (2017) (PubMed).

    Gibson, Kim, Faulkner, Evely, Pirmohamed, Park, Naisbitt: "In Vitro Priming of Naı̈ve T-cells with p-Phenylenediamine and Bandrowski's Base." in: Chemical research in toxicology, Vol. 28, Issue 10, pp. 2069-77, (2016) (PubMed).

  • Target
    IL-22 (IL22) (Interleukin 22 (IL22))
    Alternative Name
    IL22 (IL22 Products)
    Synonyms
    IL-21 antibody, IL-22 antibody, IL-D110 antibody, IL-TIF antibody, ILTIF antibody, TIFIL-23 antibody, TIFa antibody, zcyto18 antibody, IL-22a antibody, ILTIFa antibody, Iltif antibody, RGD1561292 antibody, interleukin-22 antibody, interleukin 22 antibody, IL22 antibody, il22 antibody, Il22 antibody
    Gene ID
    50616
You are here:
Support